Skip to main content
Clinical Trials/NCT05711875
NCT05711875
Completed
Not Applicable

The Effects of Using Virtual Reality Glasses on Anxiety, Stress, and Fetal Well-Being During the Non-Stress Test

Inonu University1 site in 1 country71 target enrollmentOctober 15, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pregnancy Related
Sponsor
Inonu University
Enrollment
71
Locations
1
Primary Endpoint
Anxiety scores
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The aim of this study to determine the effect of virtual reality glasses use on anxiety, stress and fetal well-being during the non-stress test. Personal information form was used as data collection form, Revised Prenatal Distress Questionnaire (NUPDQ-17 Item Version) was used to assess distress, State-Trait Anxiety Inventory (STAI) was used to assessanxiety.

Detailed Description

Material and Method This research was conducted between between October 2021 and February 2022 in Fethi Sekin City Hospital. When power analysis was performed, the sample size was calculated to be at least 71 women for each group (71 experiments, 71 controls). During the NST procedures, VR glasses were given to the participants in the experimental group by the researcher for the intervention. Data collection form for experimental and control groups before the NST procedures; Revised Prenatal Distress Questionnaire (NUPDQ-17 Item Version) and State-Trait Anxiety Inventory (STAI) were applied two times before and after NST procedure. After the NST procedures, both groups were re-administered. Descriptive statistics and independent t-test were used for data analysis.

Registry
clinicaltrials.gov
Start Date
October 15, 2021
End Date
February 1, 2022
Last Updated
2 years ago
Study Type
Interventional
Study Design
Crossover
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Mevhibe Coban

PhD student

Inonu University

Eligibility Criteria

Inclusion Criteria

  • not carrying any risk factors (e.g., preeclampsia, intrauterine growth retardation (IUGR), premature rupture of membranes, gestational diabetes)
  • having a singleton pregnancy and no vision problems
  • No uterine contraction on the tracing paper at the end of NST
  • having eaten at least two hours before NST
  • not smoking or drinking alcoholic beverages at least two hours before NST
  • having a systolic blood pressure value in the range of 90-140 mmHg and a diastolic blood pressure value in the range of 60-90 mm/Hg
  • not having any problems related to the health of the fetus (such as fetal anomaly, intrauterine growth retardation)
  • having no communication barriers.

Exclusion Criteria

  • presence of fetal distress and emergency intervention planned by the physician
  • uterine contraction as a result of NST

Outcomes

Primary Outcomes

Anxiety scores

Time Frame: NST involves 20 minutes of monitoring the fetal heart rate (FHR)

StateTrait Anxiety Scale (STAI The highest score from the scale is 80, the lowest score is 20. Higher STAI-I scores indicate higher state anxiety levels

Distress scores

Time Frame: NST involves 20 minutes of monitoring the fetal heart rate (FHR)

Revised Prenatal Distress Questionnaire (NUPDQ-17 Item Version): The highest score from the scale is 34, the lowest score is 0. Higher scores indicate higher levels of perceived prenatal distress in the respondent

Secondary Outcomes

  • Fetal Well-Being scores(NST involves 20 minutes of monitoring the fetal heart rate (FHR))

Study Sites (1)

Loading locations...

Similar Trials